Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03833089
PHASE4

Targeted Potassium Levels for Prevention of ICD Therapy

Sponsor: Rigshospitalet, Denmark

View on ClinicalTrials.gov

Summary

This study evaluates whether a rigorously controlled high-normal level of serum-potassium (4.5-5.0 mEq/L) using dietary recommendations, potassium supplements and mineralocorticoid receptor antagonists will results in a lower incidence of cardiac arrhythmias in patients with an ICD. Patients will be randomized to this treatment or a control arm, where patients will receive usual guideline recommended follow-up.

Official title: Arrhythmia Prevention in High Risk Cardiovascular Patients Using Targeted Potassium Levels

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1200

Start Date

2019-03-01

Completion Date

2035-04-01

Last Updated

2025-05-09

Healthy Volunteers

No

Interventions

COMBINATION_PRODUCT

Targeted serum potassium level

In the following order, following advices end prescriptions will be provided: 1) Potassium rich dietary advice, 2) Mineralocorticoid receptor antagonists, 3) Potassium supplementation,

Locations (3)

Gentofte University Hospital

Gentofte Municipality, Hellerup, Denmark

Roskilde University Hospital

Roskilde, Region Sjælland, Denmark

Rigshospitalet

Copenhagen, Denmark